Your browser doesn't support javascript.
loading
Incomplete penetrance for isolated congenital asplenia in humans with mutations in translated and untranslated RPSA exons.
Bolze, Alexandre; Boisson, Bertrand; Bosch, Barbara; Antipenko, Alexander; Bouaziz, Matthieu; Sackstein, Paul; Chaker-Margot, Malik; Barlogis, Vincent; Briggs, Tracy; Colino, Elena; Elmore, Aurora C; Fischer, Alain; Genel, Ferah; Hewlett, Angela; Jedidi, Maher; Kelecic, Jadranka; Krüger, Renate; Ku, Cheng-Lung; Kumararatne, Dinakantha; Lefevre-Utile, Alain; Loughlin, Sam; Mahlaoui, Nizar; Markus, Susanne; Garcia, Juan-Miguel; Nizon, Mathilde; Oleastro, Matias; Pac, Malgorzata; Picard, Capucine; Pollard, Andrew J; Rodriguez-Gallego, Carlos; Thomas, Caroline; Von Bernuth, Horst; Worth, Austen; Meyts, Isabelle; Risolino, Maurizio; Selleri, Licia; Puel, Anne; Klinge, Sebastian; Abel, Laurent; Casanova, Jean-Laurent.
Afiliación
  • Bolze A; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY 10065.
  • Boisson B; Helix, San Carlos, CA 94070.
  • Bosch B; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY 10065; bebo283@rockefeller.edu casanova@rockefeller.edu.
  • Antipenko A; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, 75015 Paris, France.
  • Bouaziz M; Imagine Institute, Paris Descartes University, 75015 Paris, France.
  • Sackstein P; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY 10065.
  • Chaker-Margot M; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY 10065.
  • Barlogis V; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, 75015 Paris, France.
  • Briggs T; Imagine Institute, Paris Descartes University, 75015 Paris, France.
  • Colino E; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY 10065.
  • Elmore AC; Laboratory of Protein and Nucleic Acid Chemistry, The Rockefeller University, New York, NY 10065.
  • Fischer A; Pediatric Hematology, University Hospital of Marseille, 13005 Marseille, France.
  • Genel F; Manchester Centre for Genomic Medicine, Saint Mary's Hospital, Manchester University Hospitals NHS Foundation Trust Manchester Academic Health Sciences Centre, Manchester M13 9WL, United Kingdom.
  • Hewlett A; Division of Evolution and Genomic Sciences, School of Biological Sciences, The University of Manchester, Manchester M13 9NT, United Kingdom.
  • Jedidi M; Department of Pediatrics, Insular Maternity and Child University Hospital Center, 35016 Las Palmas de Gran Canaria, Spain.
  • Kelecic J; National Geographic Society, Washington, DC 20036.
  • Krüger R; Imagine Institute, Paris Descartes University, 75015 Paris, France.
  • Ku CL; INSERM U1163, 75015 Paris, France.
  • Kumararatne D; Pediatric Hematology-Immunology and Rheumatology Unit, Necker Hospital for Sick Children, Assistance Publique - Hôpitaux de Paris (AP-HP), 75015 Paris, France.
  • Lefevre-Utile A; College of France, 75231 Paris, France.
  • Loughlin S; French National Reference Center for Primary Immune Deficiencies (CEREDIH), Necker Hospital for Sick Children, AP-HP, 75015 Paris, France.
  • Mahlaoui N; Pediatric Immunology, Dr. Behcet Uz Children's Hospital, 35210 Izmir, Turkey.
  • Markus S; Division of Infectious Diseases, University of Nebraska Medical Center, Omaha, NE 68198.
  • Garcia JM; Department of Legal Medicine, University Hospital Center Farhat Hached, Sousse, Tunisia.
  • Nizon M; Department of Pediatrics, University Hospital Center Zagreb, 10 000 Zagreb, Croatia.
  • Oleastro M; Department of Pediatric Pneumology, Immunology and Intensive Care, Charité - Berlin University Hospital Center, 10117 Berlin, Germany.
  • Pac M; Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University, Taoyuan City 33302, Taiwan.
  • Picard C; Department of Clinical Biochemistry and Immunology, Addenbrooke's Hospital, Cambridge University Foundation Hospitals NHS Trust, Cambridge CB2 0QQ, United Kingdom.
  • Pollard AJ; Department of Pediatrics, Infectious Diseases and Internal Medicine, Robert Debré Hospital, AP-HP, 75019 Paris, France.
  • Rodriguez-Gallego C; Molecular Genetics, Great Ormond Street Hospital, London WC1N 3JH, United Kingdom.
  • Thomas C; Imagine Institute, Paris Descartes University, 75015 Paris, France.
  • Von Bernuth H; INSERM U1163, 75015 Paris, France.
  • Worth A; Pediatric Hematology-Immunology and Rheumatology Unit, Necker Hospital for Sick Children, Assistance Publique - Hôpitaux de Paris (AP-HP), 75015 Paris, France.
  • Meyts I; French National Reference Center for Primary Immune Deficiencies (CEREDIH), Necker Hospital for Sick Children, AP-HP, 75015 Paris, France.
  • Risolino M; Medical Genetics Dr. Staber & Kollegen Laboratory, 93051 Regensburg, Germany.
  • Selleri L; Pediatric Immunology, Cruces University Hospital, 48903 Barakaldo-Vizcaya, Spain.
  • Puel A; Medical Genetics Department, University Hospital of Nantes, 44000 Nantes, France.
  • Klinge S; Department of Immunology and Rheumatology, Hospital de Pediatría J. P. Garrahan, 1249 Buenos Aires, Argentina.
  • Abel L; Department of Immunology, The Children's Memorial Health Institute, 04-730 Warsaw, Poland.
  • Casanova JL; Imagine Institute, Paris Descartes University, 75015 Paris, France.
Proc Natl Acad Sci U S A ; 115(34): E8007-E8016, 2018 08 21.
Article en En | MEDLINE | ID: mdl-30072435
ABSTRACT
Isolated congenital asplenia (ICA) is the only known human developmental defect exclusively affecting a lymphoid organ. In 2013, we showed that private deleterious mutations in the protein-coding region of RPSA, encoding ribosomal protein SA, caused ICA by haploinsufficiency with complete penetrance. We reported seven heterozygous protein-coding mutations in 8 of the 23 kindreds studied, including 6 of the 8 multiplex kindreds. We have since enrolled 33 new kindreds, 5 of which are multiplex. We describe here 11 new heterozygous ICA-causing RPSA protein-coding mutations, and the first two mutations in the 5'-UTR of this gene, which disrupt mRNA splicing. Overall, 40 of the 73 ICA patients (55%) and 23 of the 56 kindreds (41%) carry mutations located in translated or untranslated exons of RPSA. Eleven of the 43 kindreds affected by sporadic disease (26%) carry RPSA mutations, whereas 12 of the 13 multiplex kindreds (92%) carry RPSA mutations. We also report that 6 of 18 (33%) protein-coding mutations and the two (100%) 5'-UTR mutations display incomplete penetrance. Three mutations were identified in two independent kindreds, due to a hotspot or a founder effect. Finally, RPSA ICA-causing mutations were demonstrated to be de novo in 7 of the 23 probands. Mutations in RPSA exons can affect the translated or untranslated regions and can underlie ICA with complete or incomplete penetrance.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Proteínas Ribosómicas / Bazo / Biosíntesis de Proteínas / Empalme del ARN / Exones / Receptores de Laminina / Penetrancia / Síndromes de Inmunodeficiencia / Mutación Límite: Female / Humans / Male Idioma: En Revista: Proc Natl Acad Sci U S A Año: 2018 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Proteínas Ribosómicas / Bazo / Biosíntesis de Proteínas / Empalme del ARN / Exones / Receptores de Laminina / Penetrancia / Síndromes de Inmunodeficiencia / Mutación Límite: Female / Humans / Male Idioma: En Revista: Proc Natl Acad Sci U S A Año: 2018 Tipo del documento: Article